$BKLLF / $CODE   Codebase recently acquired 49% in a private pharmaceutical company which has recently filed for two US provisional patents for transdermal delivery and oral mucosal delivery of chloroquine and hydroxychloroquine. The private pharmaceutical company has a lab services agreement with Reformulation Research Laboratories Inc. (RRL), which has led the development of the patent applications and the underlying technology.  
 
https://stockhouse.com/news/press-releases/20...e-strategy  
 
$WRHLF
 
        
 (0)
(0) 
 (0)
(0)  
 
 
 
      
    
       Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!